Batch manufacture of high titer/titre GMP (U.S.A.) compliant lentiviral vector for FDA approval

University Of Edinburgh · Closed

Buyer
University Of Edinburgh
Status
Closed
Country
United Kingdom
Region
England
Sector
Professional Services
Reference
FaT-ocds-h6vhtk-056864
Published
2025-07-29
Deadline
2026-03-29

Tender summary

We are planning a phase I/II clinical trial to treat a rare genetic disease that causes progressive dementia in children. Our therapy will use autologous CD34+ haematopoietic stem progenitor cells (HSPCs) which are modified ex vivo with LVV to express supraphysiologic levels of a secreted enzyme. In order to progress this therapy, we require a high titre LVV produced to good manufacturing practice (GMP) standard. The supplier must have extensive previous experience manufacturing LVVs to this specification which have achieved regulatory approval for phase I/II clinical trials, ideally for use…

This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.

Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.

Register for full access

IT tenders · Construction tenders · Sitemap